A

ADOCIA

106 employees

Adocia is a biotechnology company specializing in tissue regeneration and developing medicines with already-approved therapeutic proteins.

Basic info

Industry

biotechnology research

Sectors

Alternative Medicine
Biotechnology
BioChaperone®
Innovative protein formulations
Therapeutic proteins
Amylin
Ultra-rapid Insulin
Metabolic diseases
Therapeutics
Diabetes
Glucagon
Multi-agents injectable combination
Next-generation injectables for diabetes treatment

Date founded

2005

Funding rounds raised

Total raised

$20M

from 5 investors over 5 rounds

A

ADOCIA raised $20M on January 27, 2010

Investors: La Caisse des Dépôts (French financial institute) and Idinvest Partners

A

ADOCIA raised $17M on January 21, 2008

Investors: Société Générale Asset Management, Smalt Capital and Idinvest Partners

FAQ